Skip to main content

What the FDA labels say about taking them together

Aliskiren and quinapril

Quinapril's FDA label of December 14, 2023 names aliskiren in its contraindications section; aliskiren's label does not name quinapril itself but warns about its class (ACE inhibitors). The quinapril label: “Do not co-administer quinapril with aliskiren in patients with diabetes.”

Check it at the source: the aliskiren FDA label on DailyMed (effective March 7, 2024, LXO US Inc.); the quinapril FDA label on DailyMed (effective December 14, 2023, Lupin Pharmaceuticals, Inc.).

What does the aliskiren label say about quinapril?

Aliskiren's label does not name quinapril itself; it warns about its class (ACE inhibitors):

Aliskiren label, warnings and precautions

In general, avoid combined use of Tekturna with ACE inhibitors or ARBs, particularly in patients with creatinine clearance (CrCl) less than 60 mL/min [see Contraindications ( 4 ), Drug Interactions ( 7 ) and Clinical Studies ( 14.3 )].

Aliskiren label, drug interactions

In general, avoid combined use of aliskiren with ACE inhibitors or ARBs, particularly in patients with CrCl less than 60 mL/min.

Source: FDA drug label (Tekturna), NDA021985 (Lxo Ireland), as published by LXO US Inc., effective March 7, 2024 (SPL set 3dd61fa5-1620-4ebf-bbdb-ede29b92fce2), via openFDA; the full label on DailyMed

What does the quinapril label say about aliskiren?

Quinapril label, contraindications

Do not co-administer quinapril with aliskiren in patients with diabetes.

Source: FDA drug label (Quinapril), Lupin Pharmaceuticals, Inc., effective December 14, 2023 (SPL set 8ded0773-3aec-4e89-9836-d22a5a84abf0), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Aliskiren generic labelers
9Quinapril generic labelers
AliskirenQuinapril
Labeled forHigh blood pressureHigh blood pressure, Heart failure
Boxed warningYesYes
Pharmacy cost (NADAC)$3.94 per tablet 150 mg tabletn/a
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?